1. Home
  2. ADVM vs MIND Comparison

ADVM vs MIND Comparison

Compare ADVM & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • MIND
  • Stock Information
  • Founded
  • ADVM 2006
  • MIND 1987
  • Country
  • ADVM United States
  • MIND United States
  • Employees
  • ADVM N/A
  • MIND N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • MIND Industrial Machinery/Components
  • Sector
  • ADVM Health Care
  • MIND Industrials
  • Exchange
  • ADVM Nasdaq
  • MIND Nasdaq
  • Market Cap
  • ADVM 47.4M
  • MIND 49.6M
  • IPO Year
  • ADVM 2014
  • MIND 1994
  • Fundamental
  • Price
  • ADVM $2.39
  • MIND $7.86
  • Analyst Decision
  • ADVM Strong Buy
  • MIND
  • Analyst Count
  • ADVM 5
  • MIND 0
  • Target Price
  • ADVM $23.80
  • MIND N/A
  • AVG Volume (30 Days)
  • ADVM 338.5K
  • MIND 519.0K
  • Earning Date
  • ADVM 08-11-2025
  • MIND 06-10-2025
  • Dividend Yield
  • ADVM N/A
  • MIND N/A
  • EPS Growth
  • ADVM N/A
  • MIND N/A
  • EPS
  • ADVM N/A
  • MIND 2.91
  • Revenue
  • ADVM $1,000,000.00
  • MIND $45,087,000.00
  • Revenue This Year
  • ADVM N/A
  • MIND $7.27
  • Revenue Next Year
  • ADVM $18.82
  • MIND N/A
  • P/E Ratio
  • ADVM N/A
  • MIND $2.79
  • Revenue Growth
  • ADVM N/A
  • MIND 26.68
  • 52 Week Low
  • ADVM $1.78
  • MIND $3.05
  • 52 Week High
  • ADVM $10.14
  • MIND $11.10
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 44.19
  • MIND 59.57
  • Support Level
  • ADVM $2.11
  • MIND $8.34
  • Resistance Level
  • ADVM $2.60
  • MIND $8.85
  • Average True Range (ATR)
  • ADVM 0.22
  • MIND 0.65
  • MACD
  • ADVM -0.00
  • MIND 0.10
  • Stochastic Oscillator
  • ADVM 33.33
  • MIND 64.53

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

Share on Social Networks: